These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8018008)

  • 1. Rifampin-induced nonresponsiveness of giant cell arteritis to prednisone treatment.
    Carrie F; Roblot P; Bouquet S; Delon A; Roblot F; Becq-Giraudon B
    Arch Intern Med; 1994 Jul; 154(13):1521-4. PubMed ID: 8018008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Giant cell arteritis after the age of 75].
    Chevalet P; Masseau-Imbert A; Durand-Fix MH; Agard C; Brisseau JM; Rodat O; Barrier JH
    Ann Med Interne (Paris); 2002 Oct; 153(6):373-7. PubMed ID: 12486385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuropathy of the common peroneal nerve caused by giant cell arteritis].
    Tomasina C; Manzino M
    Minerva Cardioangiol; 1996 Nov; 44(11):595-9. PubMed ID: 9011841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid therapy in giant cell arteritis: duration and adverse outcomes.
    Proven A; Gabriel SE; Orces C; O'Fallon WM; Hunder GG
    Arthritis Rheum; 2003 Oct; 49(5):703-8. PubMed ID: 14558057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
    Bahlas S; Ramos-Remus C; Davis P
    J Rheumatol; 1998 Jan; 25(1):99-104. PubMed ID: 9458211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cytokine and cytokine receptor levels in patients with giant cell arteritis during corticotherapy.
    Roblot P; Morel F; Lelievre E; Gascan H; Wijdenes J; Lecron JC
    J Rheumatol; 1996 Feb; 23(2):408-10. PubMed ID: 8882065
    [No Abstract]   [Full Text] [Related]  

  • 8. Change of serum calcitonin in patients receiving glucocorticoids: an acute phase study.
    Mulder H; Hackeng WH; vd Lely AJ; Siersema-Smallegange M
    Neth J Med; 1990 Jun; 36(5-6):288-90. PubMed ID: 2395496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Giant cell arteritis: diagnosis and management.
    Kachroo A; Tello C; Bais R; Panush RS
    Bull Rheum Dis; 1996 Aug; 45(5):2-5. PubMed ID: 8768498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silent, or masked, giant cell arteritis is associated with a strong inflammatory response and a benign short term course.
    Liozon E; Boutros-Toni F; Ly K; Loustaud-Ratti V; Soria P; Vidal E
    J Rheumatol; 2003 Jun; 30(6):1272-6. PubMed ID: 12784402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyalgia rheumatica and giant cell arteritis.
    Unwin B; Williams CM; Gilliland W
    Am Fam Physician; 2006 Nov; 74(9):1547-54. PubMed ID: 17111894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are steroids alone sufficient for the treatment of giant cell arteritis?
    Pipitone N; Boiardi L; Salvarani C
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):277-92. PubMed ID: 15857796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Temporal arteritis. Reduced vision during steroid treatment].
    Ljønes F; Tenstad O
    Tidsskr Nor Laegeforen; 1987 Mar; 107(9):851. PubMed ID: 3590125
    [No Abstract]   [Full Text] [Related]  

  • 14. Unusual presentations of giant cell arteritis (temporal arteritis).
    Fa'Amatuainu NA; Ng J; Kumar S; Green G
    Intern Med J; 2004 Nov; 34(11):654-5. PubMed ID: 15546466
    [No Abstract]   [Full Text] [Related]  

  • 15. Giant cell arteritis--the methotrexate debate revisited.
    Rimar D; Rozenbaum M; Zisman D; Boulman N; Slobodin G; Eder L; Feld J; Rosner I
    J Rheumatol; 2006 Jul; 33(7):1458-9. PubMed ID: 16862661
    [No Abstract]   [Full Text] [Related]  

  • 16. Giant cell (temporal) arteritis.
    Hunder GG
    Rheum Dis Clin North Am; 1990 May; 16(2):399-409. PubMed ID: 2189157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deflazacort versus prednisone in patients with giant cell arteritis: effects on bone mass loss.
    Cacoub P; Chemlal K; Khalifa P; Wechsler B; De Gennes C; Belmatoug N; Cohen P; Ziza JM; Verdoncq B; Piette JC
    J Rheumatol; 2001 Nov; 28(11):2474-9. PubMed ID: 11708421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scalp necrosis in giant cell arteritis.
    Mahevas M; Delastour V; Bussone G; Khellaf M
    J Rheumatol; 2007 Feb; 34(2):442-3. PubMed ID: 17304663
    [No Abstract]   [Full Text] [Related]  

  • 19. [Management of visual loss secondary to giant cell arteritis].
    Arruga J; Martínez J
    Arch Soc Esp Oftalmol; 2002 Dec; 77(12):645-6. PubMed ID: 12471508
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients.
    Chevalet P; Barrier JH; Pottier P; Magadur-Joly G; Pottier MA; Hamidou M; Planchon B; El Kouri D; Connan L; Dupond JL; De Wazieres B; Dien G; Duhamel E; Grosbois B; Jego P; Le Strat A; Capdeville J; Letellier P; Agron L
    J Rheumatol; 2000 Jun; 27(6):1484-91. PubMed ID: 10852275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.